(June 4, 2024, 2:30 PM EDT) -- CAMDEN, N.J. — The New Jersey federal judge presiding over the valsartan XE "valsartan" /losartan XE "losartan" /irbesartan XE "irbesartan" hypertension drugs multidistrict litigation ordered the plaintiffs and the maker of the valsartan and losartan medications to finalize the terms of the valsartan settlement of personal injury, economic loss and medical monitoring claims by June 30 and to meet with a magistrate judge to continue settlement negotiations to resolve the losartan economic loss claim....